Clinical Trials Browser

Phase 2 × Lymphoma × Idarubicin × Clear all

NCT00193973 2017-02-17

Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma

Phase 2 Completed

Lymphoma